These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


250 related items for PubMed ID: 2499250

  • 1. Activity of cefepime against ceftazidime- and cefotaxime-resistant gram-negative bacteria and its relationship to beta-lactamase levels.
    Fung-Tomc J, Dougherty TJ, DeOrio FJ, Simich-Jacobson V, Kessler RE.
    Antimicrob Agents Chemother; 1989 Apr; 33(4):498-502. PubMed ID: 2499250
    [Abstract] [Full Text] [Related]

  • 2. Activity of cefepime against ceftazidime-resistant gram-negative bacilli using low and high inocula.
    Johnson CC, Livornese L, Gold MJ, Pitsakis PG, Taylor S, Levison ME.
    J Antimicrob Chemother; 1995 Jun; 35(6):765-73. PubMed ID: 7559188
    [Abstract] [Full Text] [Related]

  • 3. [The effect of cefepime on ceftazidime, cefotaxime and imipenem resistant strains of Acinetobacter, Xanthomonas, Pseudomonas, Flavobacterium, Sphingobacterium and on producers of extended spectrum beta-lactamases (ESBL) with resistance transfer].
    Blahová J, Hupková-Lesická M, Králiková K, Krcméry V, Kubonová K.
    Cas Lek Cesk; 1997 Mar 12; 136(5):154-6. PubMed ID: 9221190
    [Abstract] [Full Text] [Related]

  • 4. Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group.
    Jones RN, Salazar JC, Pfaller MA, Doern GV.
    Diagn Microbiol Infect Dis; 1997 Dec 12; 29(4):265-72. PubMed ID: 9458984
    [Abstract] [Full Text] [Related]

  • 5. Frequency of in vitro resistance of Pseudomonas aeruginosa to cefepime, ceftazidime, and cefotaxime.
    Fung-Tomc J, Huczko E, Pearce M, Kessler RE.
    Antimicrob Agents Chemother; 1988 Sep 12; 32(9):1443-5. PubMed ID: 3143306
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
    Masuyoshi S, Hiraoka M, Inoue M, Tomatsu K, Hirano M, Mitsuhashi S.
    Drugs Exp Clin Res; 1989 Sep 12; 15(1):1-10. PubMed ID: 2663406
    [Abstract] [Full Text] [Related]

  • 7. Comparative in-vitro activities of newer cephalosporins cefclidin, cefepime, and cefpirome against ceftazidime- or imipenem-resistant Pseudomonas aeruginosa.
    Watanabe N, Hiruma R, Katsu K.
    J Antimicrob Chemother; 1992 Nov 12; 30(5):633-41. PubMed ID: 1493980
    [Abstract] [Full Text] [Related]

  • 8. Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.
    Medeiros AA, Hare R, Papa E, Adam C, Miller GH.
    J Antimicrob Chemother; 1985 Jun 12; 15 Suppl C():119-32. PubMed ID: 3875602
    [Abstract] [Full Text] [Related]

  • 9. Antimicrobial activity of cefepime tested against Bush group I beta-lactamase-producing strains resistant to ceftazidime. A multilaboratory national and international clinical isolate study.
    Jones RN, Marshall SA.
    Diagn Microbiol Infect Dis; 1994 May 12; 19(1):33-8. PubMed ID: 7956010
    [Abstract] [Full Text] [Related]

  • 10. Multicentre comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin.
    Martínez-Beltrán J, Cantón R, Liñares J, García de Lomas J, Gimeno C, Tubau F, Baquero F.
    Eur J Clin Microbiol Infect Dis; 1995 Mar 12; 14(3):244-52. PubMed ID: 7614970
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin.
    Fuchs PC, Jones RN, Barry AL, Thornsberry C.
    Antimicrob Agents Chemother; 1985 May 12; 27(5):679-82. PubMed ID: 3893316
    [Abstract] [Full Text] [Related]

  • 12. Biological activity of BO-1236, a new antipseudomonal cephalosporin.
    Nakagawa S, Sanada M, Matsuda K, Hazumi N, Tanaka N.
    Antimicrob Agents Chemother; 1987 Jul 12; 31(7):1100-5. PubMed ID: 3116919
    [Abstract] [Full Text] [Related]

  • 13. Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria.
    Mohanty S, Gaind R, Ranjan R, Deb M.
    J Infect Dev Ctries; 2009 Nov 21; 4(1):24-9. PubMed ID: 20130375
    [Abstract] [Full Text] [Related]

  • 14. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
    Jones RN, Barry AL, Thornsberry C, Gerlach EH, Fuchs PC, Gavan TL, Sommers HM.
    J Antimicrob Chemother; 1981 Sep 21; 8 Suppl B():187-211. PubMed ID: 19802985
    [Abstract] [Full Text] [Related]

  • 15. In vitro activities of cefepime alone and with amikacin against aminoglycoside-resistant gram-negative bacteria.
    Fung-Tomc J, Huczko E, Kolek B, Thater C, Kessler RE.
    Antimicrob Agents Chemother; 1991 Dec 21; 35(12):2652-4. PubMed ID: 1810203
    [Abstract] [Full Text] [Related]

  • 16. Extended-spectrum beta-lactamase-mediated resistance among bacterial isolates recovered from ocular infections.
    Jayahar Bharathi M, Ramakrishnan R, Ramesh S, Murugan N.
    Ophthalmic Res; 2012 Dec 21; 47(1):52-6. PubMed ID: 21720185
    [Abstract] [Full Text] [Related]

  • 17. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN, Sader HS, Fritsche TR, Pottumarthy S.
    Diagn Microbiol Infect Dis; 2007 Jan 21; 57(1):109-16. PubMed ID: 16930923
    [Abstract] [Full Text] [Related]

  • 18. Comparative in vitro activity of cefepime and four extended-spectrum beta-lactams on 1,251 aminoglycoside-resistant gram-negative hospital strains.
    Vanhoof R, Nulens E, Nyssen HJ, Hannecart-Pokorni E.
    Chemotherapy; 1992 Jan 21; 38(4):225-31. PubMed ID: 1473361
    [Abstract] [Full Text] [Related]

  • 19. Beta-lactamase-mediated resistance to extended spectrum cephalosporins among clinical isolates of Pseudomonas aeruginosa.
    Ben-Mahrez K, Rejiba S, Belhadj C, Belhadj O.
    Res Microbiol; 1999 Jan 21; 150(6):403-6. PubMed ID: 10466408
    [Abstract] [Full Text] [Related]

  • 20. Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group.
    Jones RN, Pfaller MA, Doern GV, Erwin ME, Hollis RJ.
    Diagn Microbiol Infect Dis; 1998 Mar 21; 30(3):215-28. PubMed ID: 9572029
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.